The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Bisodol Antacid Chewable TabletsCalcium Carbonate 522mgMagnesium Carbonate Light 68mgSodium Hydrogen Carbonate 64mg



Teva B.V.PA1986/071/001

Main Information

Trade NameBisodol Antacid Chewable TabletsCalcium Carbonate 522mgMagnesium Carbonate Light 68mgSodium Hydrogen Carbonate 64mg
Active SubstancesCalcium carbonate
Sodium hydrogen carbonate
Light magnesium carbonate
Dosage FormChewable tablet
Licence HolderTeva B.V.
Licence NumberPA1986/071/001

Group Information

ATC CodeA02AC Calcium compounds
A02AC01 calcium carbonate

Status

License statusAuthorised
Licence Issued01/04/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back